19 min listen
Haematology series | Strategies to reduce asparaginase hypersensitivity during treatment induction
Haematology series | Strategies to reduce asparaginase hypersensitivity during treatment induction
ratings:
Length:
18 minutes
Released:
Dec 1, 2020
Format:
Podcast episode
Description
Adolescent and young adult patients with acute lymphoblastic leukaemia have been shown to benefit from paediatric inspired treatment regimens, however these regimens present unique challenges when it comes to adverse-event management. Today we’ve invited Dr Patrick Brown, Director of the Paediatric Leukaemia Programme at Johns Hopkins Medicine, Baltimore, to discuss how to reduce the risk of adverse events in these settings.
Access more free education today! Visit the website, follow us on Twitter (@onckip) or connect on LinkedIn.
References:
- Silverman LB, et al. Blood. 2001; 97(5):1211-8.
- Verma A, et al. Pediatr Hematol Oncol. 2019; 36(5):277-286.
- Baruchel A, et al. ESMO Open 2020;5:e000977
- Cooper SL, et al. Pediatr Blood Cancer. 2019; 66(8):e27797.
- Verma A, et al. Blood. 2018; 132(Suppl 1):5205
- Marini BL, et al. Leuk Lymphoma. 2019; 60(12):2854-2868.
This independent educational activity is supported by educational grants from Servier Pharmaceuticals LLC and Takeda. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Servier and Takeda have had no influence on the content of this education.
Access more free education today! Visit the website, follow us on Twitter (@onckip) or connect on LinkedIn.
References:
- Silverman LB, et al. Blood. 2001; 97(5):1211-8.
- Verma A, et al. Pediatr Hematol Oncol. 2019; 36(5):277-286.
- Baruchel A, et al. ESMO Open 2020;5:e000977
- Cooper SL, et al. Pediatr Blood Cancer. 2019; 66(8):e27797.
- Verma A, et al. Blood. 2018; 132(Suppl 1):5205
- Marini BL, et al. Leuk Lymphoma. 2019; 60(12):2854-2868.
This independent educational activity is supported by educational grants from Servier Pharmaceuticals LLC and Takeda. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Servier and Takeda have had no influence on the content of this education.
Released:
Dec 1, 2020
Format:
Podcast episode
Titles in the series (32)
Immunotherapy series | Consensus best practice approaches to metastatic head and neck squamous cell carcinoma (HNSCC) by Oncology Knowledge into Practice Podcast